Global Apigeninidin 麻豆原创 Growth 2025-2031

Publication ID:

LPI04255909

Publication Date:

April 24, 2025

Pages:

140

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Apigeninidin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Apigeninidin (Also, apigenidin,or Gesneridin) is a chemical compound belonging to the 3-deoxyanthocyanidins and that can be found in the Patagonian plant Ephedra frustillata and in the soybean. Apigeninidin is one of the principal pigments found in sorghum. Extremely high level of apigeninidin (49 mg/g) has been documented in sorghum leaf sheath. Like all anthocyanidins it exists in a variety of tautomers depending on pH and hydration, several of these bare the distinctive pyrylium core.Apigenin is a protein kinase inhibitor. Suppresses tumor-promoting effects of TPA and exhibits antiproliferative activity in human breast cancer cells (IC50 values are 59.44 and 31.15 渭M at 24 and 72 hrs respectively). Activates both the intrinsic and extrinsic apoptotic pathways and displays anti-inflammatory, hypotensive, antispasmodic and antioxidant properties in vivo.Apigenin, found in many plants, is a natural product belonging to the flavone class that is the aglycone of several naturally-occurring glycosides. Apigenin acts as a monoamine transporter activator, one of the few chemicals demonstrated to possess this property. Apigenin is a ligand for central benzodiazepine receptors that competitively inhibited the binding of flunitrazepam with a Ki of 4渭M, exerting anxiolytic and slight sedative effects.
United States market for Apigeninidin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Apigeninidin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Apigeninidin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Apigeninidin players cover Bio-techne, Creative Enzymes, MedChemExpress, Biosynth Carbosynth, United States Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淎pigeninidin Industry Forecast鈥� looks at past sales and reviews total world Apigeninidin sales in 2024, providing a comprehensive analysis by region and market sector of projected Apigeninidin sales for 2025 through 2031. With Apigeninidin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Apigeninidin industry.
This Insight Report provides a comprehensive analysis of the global Apigeninidin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Apigeninidin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Apigeninidin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Apigeninidin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Apigeninidin.
This report presents a comprehensive overview, market shares, and growth opportunities of Apigeninidin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Powder
Crystalline Solid
Others
Segmentation by Application:
Food Industry
Medical Care
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bio-techne
Creative Enzymes
MedChemExpress
Biosynth Carbosynth
United States Biological
Molekula
BOC Sciences
FoodChem
Focus Biomolecules
Ottokemi
BioCrick
Lanyor
NEO Biotech
ChemFaces
Cayman
Sigma-Aldrich
Key Questions Addressed in this Report
What is the 10-year outlook for the global Apigeninidin market?
What factors are driving Apigeninidin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Apigeninidin market opportunities vary by end market size?
How does Apigeninidin break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Apigeninidin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Apigeninidin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Apigeninidin by Country/Region, 2020, 2024 & 2031
2.2 Apigeninidin Segment by Type
2.2.1 Powder
2.2.2 Crystalline Solid
2.2.3 Others
2.3 Apigeninidin Sales by Type
2.3.1 Global Apigeninidin Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Apigeninidin Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Apigeninidin Sale Price by Type (2020-2025)
2.4 Apigeninidin Segment by Application
2.4.1 Food Industry
2.4.2 Medical Care
2.4.3 Scientific Research
2.4.4 Others
2.5 Apigeninidin Sales by Application
2.5.1 Global Apigeninidin Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Apigeninidin Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Apigeninidin Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Apigeninidin Breakdown Data by Company
3.1.1 Global Apigeninidin Annual Sales by Company (2020-2025)
3.1.2 Global Apigeninidin Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Apigeninidin Annual Revenue by Company (2020-2025)
3.2.1 Global Apigeninidin Revenue by Company (2020-2025)
3.2.2 Global Apigeninidin Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Apigeninidin Sale Price by Company
3.4 Key Manufacturers Apigeninidin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Apigeninidin Product Location Distribution
3.4.2 Players Apigeninidin Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Apigeninidin by Geographic Region
4.1 World Historic Apigeninidin 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Apigeninidin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Apigeninidin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Apigeninidin 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Apigeninidin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Apigeninidin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Apigeninidin Sales Growth
4.4 APAC Apigeninidin Sales Growth
4.5 Europe Apigeninidin Sales Growth
4.6 Middle East & Africa Apigeninidin Sales Growth
5 Americas
5.1 Americas Apigeninidin Sales by Country
5.1.1 Americas Apigeninidin Sales by Country (2020-2025)
5.1.2 Americas Apigeninidin Revenue by Country (2020-2025)
5.2 Americas Apigeninidin Sales by Type (2020-2025)
5.3 Americas Apigeninidin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Apigeninidin Sales by Region
6.1.1 APAC Apigeninidin Sales by Region (2020-2025)
6.1.2 APAC Apigeninidin Revenue by Region (2020-2025)
6.2 APAC Apigeninidin Sales by Type (2020-2025)
6.3 APAC Apigeninidin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Apigeninidin by Country
7.1.1 Europe Apigeninidin Sales by Country (2020-2025)
7.1.2 Europe Apigeninidin Revenue by Country (2020-2025)
7.2 Europe Apigeninidin Sales by Type (2020-2025)
7.3 Europe Apigeninidin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Apigeninidin by Country
8.1.1 Middle East & Africa Apigeninidin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Apigeninidin Revenue by Country (2020-2025)
8.2 Middle East & Africa Apigeninidin Sales by Type (2020-2025)
8.3 Middle East & Africa Apigeninidin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Apigeninidin
10.3 Manufacturing Process Analysis of Apigeninidin
10.4 Industry Chain Structure of Apigeninidin
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Apigeninidin Distributors
11.3 Apigeninidin Customer
12 World Forecast Review for Apigeninidin by Geographic Region
12.1 Global Apigeninidin 麻豆原创 Size Forecast by Region
12.1.1 Global Apigeninidin Forecast by Region (2026-2031)
12.1.2 Global Apigeninidin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Apigeninidin Forecast by Type (2026-2031)
12.7 Global Apigeninidin Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Bio-techne
13.1.1 Bio-techne Company Information
13.1.2 Bio-techne Apigeninidin Product Portfolios and Specifications
13.1.3 Bio-techne Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bio-techne Main Business Overview
13.1.5 Bio-techne Latest Developments
13.2 Creative Enzymes
13.2.1 Creative Enzymes Company Information
13.2.2 Creative Enzymes Apigeninidin Product Portfolios and Specifications
13.2.3 Creative Enzymes Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Creative Enzymes Main Business Overview
13.2.5 Creative Enzymes Latest Developments
13.3 MedChemExpress
13.3.1 MedChemExpress Company Information
13.3.2 MedChemExpress Apigeninidin Product Portfolios and Specifications
13.3.3 MedChemExpress Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 MedChemExpress Main Business Overview
13.3.5 MedChemExpress Latest Developments
13.4 Biosynth Carbosynth
13.4.1 Biosynth Carbosynth Company Information
13.4.2 Biosynth Carbosynth Apigeninidin Product Portfolios and Specifications
13.4.3 Biosynth Carbosynth Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Biosynth Carbosynth Main Business Overview
13.4.5 Biosynth Carbosynth Latest Developments
13.5 United States Biological
13.5.1 United States Biological Company Information
13.5.2 United States Biological Apigeninidin Product Portfolios and Specifications
13.5.3 United States Biological Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 United States Biological Main Business Overview
13.5.5 United States Biological Latest Developments
13.6 Molekula
13.6.1 Molekula Company Information
13.6.2 Molekula Apigeninidin Product Portfolios and Specifications
13.6.3 Molekula Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Molekula Main Business Overview
13.6.5 Molekula Latest Developments
13.7 BOC Sciences
13.7.1 BOC Sciences Company Information
13.7.2 BOC Sciences Apigeninidin Product Portfolios and Specifications
13.7.3 BOC Sciences Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BOC Sciences Main Business Overview
13.7.5 BOC Sciences Latest Developments
13.8 FoodChem
13.8.1 FoodChem Company Information
13.8.2 FoodChem Apigeninidin Product Portfolios and Specifications
13.8.3 FoodChem Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 FoodChem Main Business Overview
13.8.5 FoodChem Latest Developments
13.9 Focus Biomolecules
13.9.1 Focus Biomolecules Company Information
13.9.2 Focus Biomolecules Apigeninidin Product Portfolios and Specifications
13.9.3 Focus Biomolecules Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Focus Biomolecules Main Business Overview
13.9.5 Focus Biomolecules Latest Developments
13.10 Ottokemi
13.10.1 Ottokemi Company Information
13.10.2 Ottokemi Apigeninidin Product Portfolios and Specifications
13.10.3 Ottokemi Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ottokemi Main Business Overview
13.10.5 Ottokemi Latest Developments
13.11 BioCrick
13.11.1 BioCrick Company Information
13.11.2 BioCrick Apigeninidin Product Portfolios and Specifications
13.11.3 BioCrick Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 BioCrick Main Business Overview
13.11.5 BioCrick Latest Developments
13.12 Lanyor
13.12.1 Lanyor Company Information
13.12.2 Lanyor Apigeninidin Product Portfolios and Specifications
13.12.3 Lanyor Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Lanyor Main Business Overview
13.12.5 Lanyor Latest Developments
13.13 NEO Biotech
13.13.1 NEO Biotech Company Information
13.13.2 NEO Biotech Apigeninidin Product Portfolios and Specifications
13.13.3 NEO Biotech Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 NEO Biotech Main Business Overview
13.13.5 NEO Biotech Latest Developments
13.14 ChemFaces
13.14.1 ChemFaces Company Information
13.14.2 ChemFaces Apigeninidin Product Portfolios and Specifications
13.14.3 ChemFaces Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 ChemFaces Main Business Overview
13.14.5 ChemFaces Latest Developments
13.15 Cayman
13.15.1 Cayman Company Information
13.15.2 Cayman Apigeninidin Product Portfolios and Specifications
13.15.3 Cayman Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Cayman Main Business Overview
13.15.5 Cayman Latest Developments
13.16 Sigma-Aldrich
13.16.1 Sigma-Aldrich Company Information
13.16.2 Sigma-Aldrich Apigeninidin Product Portfolios and Specifications
13.16.3 Sigma-Aldrich Apigeninidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Sigma-Aldrich Main Business Overview
13.16.5 Sigma-Aldrich Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.